• Summary

    the objective of the current research is to develop modified lipidic nanoparticles loaded with an anticancer drug (baicalin), to overcome the blood brain barrier and to exhibit beneficial therapeutic outcome in the treatment of glioma.

  • Achievements


  • List of Publications from the Project


  • Partners

  • Project Members

  • Project Leaders

  • Project PI

    Maha Nasr

  • Faculty

    Faculty of Pharmacy

  • Research Group

  • Funding Agency

    STDF / STIFA

  • Funding Program

    Demand-Driven Projects (STDF-DDP)

  • Start Date

    2020-11-20

  • End Date

    2021-11-20

  • Project website